Clinical Trials
56 trialsREGINA
Jules Bordet Institute
A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma
National Cancer Institute (NCI)
Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer
National Cancer Institute (NCI)
COMET
Alliance Foundation Trials, LLC.
SUGAR
Institut Claudius Regaud
Testing the Role of FDG-PET/CT to Predict Response to Therapy Prior to Surgery for HER2-positive Breast Cancer, The DIRECT Trial
Eastern Cooperative Oncology Group
Phase II Trial of Adjuvant Cisplatin and Radiation With Pembrolizumab in Resected Head and Neck Squamous Cell Carcinoma
University of Cincinnati
Risk-Adapted Focal Proton Beam Radiation and/or Surgery in Patients With Low, Intermediate and High Risk Rhabdomyosarcoma Receiving Standard or Intensified Chemotherapy
St. Jude Children's Research Hospital
Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
St. Jude Children's Research Hospital
Femoral Bone Metastases
University Health Network, Toronto
A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma
St. Jude Children's Research Hospital
IL Believe
Ascendis Pharma A/S
Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors
St. Jude Children's Research Hospital
Surgical Nivolumab And Ipilimumab For Recurrent GBM
Dana-Farber Cancer Institute
Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
Children's Oncology Group
Camrelizumab Plus Apatinib in Combination With GEMOX (Gemcitabine and Oxaliplatin ) in Patients With Locally Advanced Biliary Tract Cancer
First Affiliated Hospital of Zhejiang University
Neoadjuvant Intralesional Injection of Talimogene Laherparepvec
University of Iowa
ILDR-03
Shantou University Medical College
ERASIN-RCT
Azienda Ospedaliera Universitaria Integrata Verona
INTerpath-005
Merck Sharp & Dohme LLC
BREAST
Centre Georges Francois Leclerc
Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients
M.D. Anderson Cancer Center
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Washington University School of Medicine
Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function
Lithuanian University of Health Sciences
PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy
University of Southern California
Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
UNC Lineberger Comprehensive Cancer Center
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Massachusetts General Hospital
Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer
First Affiliated Hospital of Guangxi Medical University
A Study of Abemaciclib in Recurrent Glioblastoma
Dana-Farber Cancer Institute
KEYNOTE-866
Merck Sharp & Dohme LLC
KEYNOTE-905
Merck Sharp & Dohme LLC
Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）
Shanghai Chest Hospital
KEYNOTE-756
Merck Sharp & Dohme LLC
CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer
Alliance Foundation Trials, LLC.
AEGEAN
AstraZeneca
ORCHESTRA
Radboud University Medical Center
3 Tesla MRI in Patients With Bladder Cancer
University of Cincinnati
NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
RenJi Hospital
Afatinib With CT and RT for EGFR-Mutant NSCLC
Massachusetts General Hospital
Pivotal
Philogen S.p.A.
Neoadjuvant Tislelizumab in Combination With Dasatinib and Quercetin in Resectable HNSCC (COIS-01)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
GRECCAR15
University Hospital, Bordeaux
Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC
Ruijin Hospital
NETest_Sx
Wren Laboratories LLC
APP
RenJi Hospital
MORE-T
Seoul National University Hospital
APTneo
Fondazione Michelangelo
Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node
Institut Paoli-Calmettes
TESS
Sun Yat-sen University